Bipolar disorder Paul Harrison Warneford Hospital Bipolar disorder - - PowerPoint PPT Presentation
Bipolar disorder Paul Harrison Warneford Hospital Bipolar disorder - - PowerPoint PPT Presentation
Bipolar disorder Paul Harrison Warneford Hospital Bipolar disorder guidelines NICE (2014) British Association for Psychopharmacology (Goodwin et al, 2016, J. Psychopharmacol . 30: 495-553) Covers all aspects Independent
SLIDE 1
SLIDE 2
Bipolar disorder guidelines
- NICE (2014)
- British Association for Psychopharmacology (Goodwin et al,
2016, J. Psychopharmacol. 30: 495-553)
– Covers all aspects – Independent – Available free from website: https://www.bap.org.uk/guidelines
- Also BAP guidelines for psychotropic prescribing in
pregnancy/breastfeeding (2017), and off-label prescribing (2017)
SLIDE 3
Troublesome terms
- Mania vs hypomania
– Mania = mood elevation etc, with functional impairment. – Hypomania = mood elevation (and increased energy) unequivocal, but it does not cause marked functional impairment – Both need to be present for 7 days (though DSM-5 requires
- nly 4 days for hypomania)
- Bipolar I vs Bipolar II
– American (DSM) terms – BD1 = ‘true’ BD, with mania – BD2 = milder BD, with hypomania (and depression).
SLIDE 4
Majority of BD presents with one or more depressive episodes first, so how to spot BD?
- Screening for undiagnosed past hypomania
– Episode(s) of increased energy/disinhibition/reduced sleep/grandiosity/irritability – Out-of-character/caused problems/regretted – How long? – Was patient on an antidepressant/stimulant at the time?
- Family history of BD
SLIDE 5
- Differential diagnosis
– Borderline PD (emotionally unstable PD) – Cyclothymia – ‘Organic’ bipolar disorder
- Especially if onset >40, unexpected
- Steroids, L-DOPA, thyroid, cortical lesions
– Schizoaffective disorder – (A ‘degree’ of BD)
- Comorbidities/confounders
– The rule not the exception – Alcohol and drugs – Anxiety disorders
- Often persistent, and not explained by mood
SLIDE 6
BD vs borderline PD (BPD)
- Distinguishing features of BPD
– Personality not illness – Pervasive efforts to avoid abandonment – Features fluctuate in response to relationships, e.g. ‘acting
- ut’ and anger
– Chronic feeling of emptiness, depressive symptoms, poor self-image – Absence of true hypomanic episodes – (Differences in characteristics of mood instability)
- Comorbid in 20%
– Worse outcomes – BPD ‘blinds clinician to diagnosis of BD’ (and its therapy) – Presence of BPD increases case for psychotherapy
SLIDE 7
Bipolar depression
- Causes far more morbidity than the manic phase
- SSRIs (and other antidepressants) are largely ineffective
and may precipitate hypomania or rapid cycling
- Hence recognition of bipolarity is important, as leads to
different treatment algorithm
- Clinically similar to unipolar depression, but
– Melancholic, psychotic, or atypical features raise suspicion – Plus family history and past history mentioned earlier
SLIDE 8
Fluoxetine +
- lanzapine
Quetiapine First line Second line Fluoxetine +
- lanzapine
Lamotrigine Quetiapine Quetiapine + lamotrigine
Drug treatment of bipolar depression
Olanzapine
SLIDE 9
Bipolar depression (2)
- Quetiapine:
– Strong evidence – (A bit) less weight gain/metabolic syndrome than
- lanzapine
– Anxiety and sedation – Dose varies widely
- Start low, warn about sedation
- Often <300mg/d needed
SLIDE 10
Bipolar depression (3)
- Lamotrigine
– Reasonable effect as sole agent – Useful adjunct if first-line Rx ineffective – Well tolerated – But slow titration, risk of Stevens-Johnson syndrome – CHC
- Reduces lamotrigine levels (so risks of toxicity in pill-free week)
- Either avoid CHC, or use continuous regimen
SLIDE 11
Lamotrigine augments quetiapine in bipolar depression
Lancet Psychiatry 2016:3:31-39 Weeks
NB: Lamotrigine response impaired by folic acid Effective over 12 months: 36% in remission, vs 16% in placebo group
SLIDE 12
Psychosocial aspects of BD
- Psychoeducation
– Identify triggers – Recognise early signs – Early intervention (e.g. sleep hygiene, hypnotics) – Importance of medication, and compliance – Involve family
- Lifestyle advice
– Regular routines, avoid drugs and alcohol
- Other formal psychotherapies
– Little evidence (including for CBT)
SLIDE 13
Fluoxetine +
- lanzapine
Quetiapine First line Second line Fluoxetine +
- lanzapine
Lamotrigine Quetiapine Quetiapine + lamotrigine
Third line Add valproate Lurasidone (not licensed for BD in UK) ECT
Drug treatment of bipolar depression
Olanzapine
Add lithium
NB: Limited evidence for all compared to unipolar depression
Aripiprazole (resistant cases)
SLIDE 14
Prophylaxis
- Consider after a single manic episode, and definitely after two
- Lithium – remains first line
– Anti-suicidal effect
- Valproate
- Lithium + valproate
- Quetiapine
- Lamotrigine
– Not good anti-manic
- Carbamazepine – weak evidence, now rarely used
- Stopping prophylaxis: difficult decision, often better to
continue
– Always taper very gradually (especially lithium)
- Naturalistic data interesting…
SLIDE 15
JAMA Psychiatry AOL 28.2.18
18,000 BD patients followed for 25 years 9,000 admissions
SLIDE 16
Overall, lithium did best
SLIDE 17
Quetiapine had only modest benefits – and olanzapine none
SLIDE 18
Depot antipsychotics did much better than
- ral
…compliance
SLIDE 19
BD in women of child-bearing age
- Pros and cons of meds vs no meds, and which one
- High risk of relapse during and after pregnancy
- BD itself associated with increased risk of adverse
pregnancy outcomes
- Ideally, discussion and monitoring pre-conception
- Avoid valproate
- Lithium – less risky than thought
– cardiac malformations in 2.4% vs 1.2%
- Lamotrigine, quetiapine, olanzapine – relatively safe
– as is lithium after first trimester
SLIDE 20
Physical health monitoring
- Same excess mortality and cardiovascular risks as
schizophrenia
- Physical health checks recommended for mood
stabilisers as for antipsychotics
- Lithium monitoring (levels, renal, thyroid, calcium)
- Guidelines and protocols for both are under review
SLIDE 21
Services for BD
- BD omitted from NSF
– Significance and needs neglected – Refer to AMHT or EIS in usual way
- Specialist BD clinic run at Warneford by academic
psychiatrists
– For research studies, especially clinical trials – Remote mood monitoring – Not an emergency service; not complex or chronic cases – Referrals/queries to oxfordhealth.bipolarclinic@nhs.net – Leaflets
SLIDE 22
https://oxfordhealth.truecolours.nhs.uk/www/
SLIDE 23
Questions?
SLIDE 24
SLIDE 25